Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aero...

FDA Recall #D-0379-2015 — Class II — December 31, 2014

Recall #D-0379-2015 Date: December 31, 2014 Classification: Class II Status: Terminated

Product Description

Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.

Reason for Recall

Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.

Recalling Firm

Valeant Pharmaceuticals North America LLC — Bridgewater, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2,428 vials

Distribution

Nationwide and Australia

Code Information

Lot #: 340353F, Exp 10/2018

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated